Bortoletto R, Garzitto M, Piscitelli F, Fornasaro S, Scipioni C, Sepulcri O
Brain Sci. 2025; 14(12.
PMID: 39766429
PMC: 11727594.
DOI: 10.3390/brainsci14121230.
Frearson G, de Otazu Olivares J, Catalan A, Aymerich C, Salazar de Pablo G
Child Adolesc Ment Health. 2024; 30(1):66-82.
PMID: 39688301
PMC: 11754713.
DOI: 10.1111/camh.12755.
Devoe D, Liu L, Braun A, Cadenhead K, Cornblatt B, Granholm E
Can J Psychiatry. 2024; 70(3):217-228.
PMID: 39529289
PMC: 11562941.
DOI: 10.1177/07067437241295636.
Teigset C, Mohn C, Mohn-Haugen C, Laroi F, Rund B
Front Psychol. 2024; 15:1430805.
PMID: 39355295
PMC: 11443346.
DOI: 10.3389/fpsyg.2024.1430805.
Accinni T, Buzzanca A, Frascarelli M, Carlone L, Ghezzi F, Kotzalidis G
Schizophr Bull Open. 2024; 3(1):sgab049.
PMID: 39144801
PMC: 11205897.
DOI: 10.1093/schizbullopen/sgab049.
-Acetylcysteine and a Specialized Preventive Intervention for Individuals at High Risk for Psychosis: A Randomized Double-Blind Multicenter Trial.
Wasserthal S, Muthesius A, Hurlemann R, Ruhrmann S, Schmidt S, Hellmich M
Schizophr Bull Open. 2024; 5(1):sgae005.
PMID: 39144108
PMC: 11207905.
DOI: 10.1093/schizbullopen/sgae005.
Associations between interpersonal trauma and social impairments in adolescents with and without a family history of psychosis.
Deam M, Gupta T, Bridgwater M, Haas G, Horton L
Schizophr Res. 2024; 264:280-281.
PMID: 38198880
PMC: 11867766.
DOI: 10.1016/j.schres.2024.01.002.
Polygenic risk for schizophrenia, social dispositions, and pace of epigenetic aging: Results from the Young Finns Study.
Saarinen A, Marttila S, Mishra P, Lyytikainen L, Raitoharju E, Mononen N
Aging Cell. 2023; 23(3):e14052.
PMID: 38031635
PMC: 10928579.
DOI: 10.1111/acel.14052.
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review.
Melillo A, Caporusso E, Giordano G, Giuliani L, Pezzella P, Perrottelli A
J Clin Med. 2023; 12(22).
PMID: 38002707
PMC: 10672428.
DOI: 10.3390/jcm12227095.
Mentalizing in individuals with state and trait risk for psychosis: a systematic review.
De Salve F, Rossi C, Oasi O
Front Psychiatry. 2023; 14:1214385.
PMID: 37915797
PMC: 10616828.
DOI: 10.3389/fpsyt.2023.1214385.
Cognitive-Behavioral Social Skills Training: Outcome of a Randomized Controlled Trial for Youth at Risk of Psychosis.
Addington J, Liu L, Braun A, Brummitt K, Cadenhead K, Cornblatt B
Schizophr Bull Open. 2023; 4(1):sgad020.
PMID: 37601286
PMC: 10439516.
DOI: 10.1093/schizbullopen/sgad020.
Temporal Interactions Between Social Motivation and Behavior In Daily Life Among Individuals at Clinical High-Risk for Psychosis.
Strauss G, Raugh I, Luther L, Walker E, Mittal V
Schizophr Bull. 2023; 49(5):1150-1160.
PMID: 37467481
PMC: 10483454.
DOI: 10.1093/schbul/sbad096.
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized Trial.
McGorry P, Mei C, Amminger G, Yuen H, Kerr M, Spark J
JAMA Psychiatry. 2023; 80(9):875-885.
PMID: 37378974
PMC: 10308298.
DOI: 10.1001/jamapsychiatry.2023.1947.
Childhood maltreatment and social functioning in psychotic disorders: a systematic review protocol.
Fares-Otero N, Pfaltz M, Rodriguez-Jimenez R, Schafer I, Trautmann S
Eur J Psychotraumatol. 2023; 12(1):1943872.
PMID: 36877473
PMC: 10075514.
DOI: 10.1080/20008198.2021.1943872.
Clinical and cost-effectiveness of social recovery therapy for the prevention and treatment of long-term social disability among young people with emerging severe mental illness (PRODIGY): randomised controlled trial.
Berry C, Hodgekins J, French P, Clarke T, Shepstone L, Barton G
Br J Psychiatry. 2022; 220(3):154-162.
PMID: 35078555
PMC: 7612415.
DOI: 10.1192/bjp.2021.206.
Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study.
Paetzold I, Hermans K, Schick A, Nelson B, Velthorst E, Schirmbeck F
JMIR Ment Health. 2021; 8(11):e30309.
PMID: 34807831
PMC: 8663470.
DOI: 10.2196/30309.
Transition to psychosis in randomized clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis.
Salazar de Pablo G, Davies C, de Diego H, Solmi M, Shin J, Carvalho A
Eur Psychiatry. 2021; 64(1):e51.
PMID: 34315555
PMC: 8390336.
DOI: 10.1192/j.eurpsy.2021.2222.
Telepsychotherapy with Youth at Clinical High Risk for Psychosis: Clinical Issues and Best Practices during the COVID-19 Pandemic.
DeLuca J, Andorko N, Chibani D, Jay S, Rakhshan Rouhakhtar P, Petti E
J Psychother Integr. 2021; 30(2):304-331.
PMID: 34305369
PMC: 8297958.
DOI: 10.1037/int0000211.
Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis.
Salazar de Pablo G, Besana F, Arienti V, Catalan A, Vaquerizo-Serrano J, Cabras A
EClinicalMedicine. 2021; 36:100909.
PMID: 34189444
PMC: 8219991.
DOI: 10.1016/j.eclinm.2021.100909.
Cognitive Behavioral Therapy for Prodromal Stage of Psychosis-Outcomes for Transition, Functioning, Distress, and Quality of Life: A Systematic Review and Meta-analysis.
Zheng Y, Xu T, Zhu Y, Li C, Wang J, Livingstone S
Schizophr Bull. 2021; 48(1):8-19.
PMID: 33944949
PMC: 8781350.
DOI: 10.1093/schbul/sbab044.